TITLE:
Multicenter Trial For Patients With Acute Crohn's Disease

CONDITION:
Crohn's Disease

INTERVENTION:
etiprednol dicloacetate

SUMMARY:

      The purpose of this study is to see if etiprednol dicloacetate is safe and effective for the
      treatment of acute Crohn's disease.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        -  Must have active confirmed Crohn's disease with CDAI > 220 and < 400.

          -  Otherwise healthy.
      
